期刊文献+

一氧化氮和一氧化氮合酶基因多态性与糖尿病视网膜病变 被引量:6

NO and NOS on genetic polymorphisms of diabetic retinopathy
下载PDF
导出
摘要 糖尿病视网膜病变(diabetic retinopathy,DR)是重要致盲性眼病之一,其发生和进展与血糖水平、疾病病程、环境及遗传等多种因素有关。一氧化氮(NO)作为一种重要的血管活性物质,与DR中毛细血管闭塞、微循环障碍、内皮细胞增殖相关。一氧化氮合成酶(NOS)是NO合成过程中的关键酶,我们就NO和NOS基因多态性与DR的关系进行综述。 Diabetic retinopathy (DR)is one of important eye diseases that may cause blindness. Its occurrence and development is related to blood glucose level, duration of diabetes,environment and genetics. Nitric oxide (NO) is an important vasoactive substance which correlate with capillary occlusion, microcirculation disturbance, endothelial cell proliferation in DR. Nitric oxide synthase (NOS) is now accepted as a key enzyme of NO synthesis. The functions of NO and NOS on genetic polymorphism to DR are summarized in this review.
出处 《国际眼科杂志》 CAS 2010年第11期2144-2146,共3页 International Eye Science
关键词 糖尿病视网膜病变 一氧化氮 一氧化氮合成酶 基因多态性 diabetic retinopathy nitric oxide nitric oxide synthase genetic polymorphism
  • 相关文献

参考文献25

  • 1Bitar MS,Wahid S,Mnstafa S,et al.Nitric oxide dynamics and endothelial dysfunction in type Ⅱ model of genetic diabetes.Eur J Pharmacol2005;511(1):53-64.
  • 2Bohme GA,Bon C,Stutzmann JM,et al.Possible involvement of nit ric oxide in long term potentiation.Eur J Pharmacol 1991 ;199(3):379-381.
  • 3Liu RH,Hotchkiss TH.Potential genotoxicity of chronically elevatednit ric oxide a reviews.Mutal Res 1995;339(2):73-89.
  • 4Chakravarthy U,Stitt AW,Mcnally J,et al.Nitric oxide synt hase activity and expression in retinal capillary endothelial cells and pericytes.Curr Eye Res 1995;14(2):285-294.
  • 5Bogdan C.Nitric oxide and the regulation of gene expression.Trends Cell Biol 2001 ;11(2):66-75.
  • 6杜红阳,付海燕,刘丹,孙鹏.血浆ET-1、NO和vWF与2型糖尿病视网膜病变相关关系[J].眼科新进展,2006,26(9):685-687. 被引量:12
  • 7罗大卫,许迅.氨基胍与糖尿病视网膜病变[J].眼科新进展,2002,22(3):206-208. 被引量:14
  • 8王梅,文艳玲,李海刚,蓝育青,刘嫣芬,朱邦豪.糖尿病视网膜病变前期NOS亚型的蛋白表达及其在血流变化中作用的实验研究[J].中山大学学报(医学科学版),2004,25(4):342-346. 被引量:3
  • 9Clermont AC,Takahara H,Kngokawa H,et al.In vivo transduction of epithet-Lial nitric oxide synthase(eNOS)via adenovirus infection in diabetic rats enhances retinal hemodynamics.Invest Opthalmol Vis Sci 1999 ;40:680.
  • 10Warpeha KM,Xu W,Liu IG,et al.Genotype and functional analysis of a polymorphic(CCTIT)n repeat of NOS2A in diabetic retinopathy.FASEB J 1999 ; 13:1825-1832.

二级参考文献46

  • 1张雪莲,傅汉菁,潘素芳,谢荣荣.糖尿病视网膜病变与血管性血友病因子和纤维蛋白原的关系[J].微循环学杂志,2004,14(3):51-52. 被引量:4
  • 2张敏,刘华,徐玉善,王玉明,宋滇平,李红.2型糖尿病患者eNOS基因第4内含子的多态性与糖尿病视网膜病相关性[J].中华内分泌代谢杂志,2005,21(2):146-147. 被引量:5
  • 3殷红涛,张明,唐健,张军军.糖尿病视网膜病变候选基因研究[J].中华眼底病杂志,2006,22(2):144-146. 被引量:7
  • 4中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 5American Diabetes Association.Diabetic retinopathy.Diabetes Care,1998,21:157-159.
  • 6Leslie RDG,Pyke DA.Diabetic retinopathy in identical twins.Diabetes,1982,31:19-21.
  • 7Harris EL,Feldman S,Robinson CR,et al.Racial differences in therelationship between blood pressure and risk of retinopathy among individuals with NIDDM.Diabetes Care,1993,16:748-754.
  • 8Barbosa J,Saner B.Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia,1984,27:487-492.
  • 9The Diabetes Control and Complications Trial Research Group.The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and domplications trial.Diabetes,1995,44:968-983.
  • 10Agardh D,Gaur LK,Agardh E,et al.HLA-DQB1 * 02 01/ 0302 is associated with severe retinopathy in patients with IDDM.Diabetologia,1996,39:1313-1317.

共引文献27

同被引文献63

  • 1王梅,文艳玲,李海刚,蓝育青,刘嫣芬,朱邦豪.糖尿病视网膜病变前期NOS亚型的蛋白表达及其在血流变化中作用的实验研究[J].中山大学学报(医学科学版),2004,25(4):342-346. 被引量:3
  • 2叶晓峰,张勇进,田洁.葛根芩连加味汤对糖尿病大鼠视网膜病变的防治作用[J].中国中医眼科杂志,2006,16(1):34-37. 被引量:17
  • 3袁爱花,梅妍,周鸿鹰,项涛,羊惠君.一氧化氮合酶在糖尿病大鼠视网膜中表达模式的研究[J].南方医科大学学报,2007,27(4):454-457. 被引量:5
  • 4郭凯,韩萍.糖尿病性黄斑水肿的研究进展[J].国际眼科杂志,2007,7(2):478-480. 被引量:23
  • 5Franklin SW, Rajan SE. An automated retinal imaging method for the early diagnosis of diabetic retinopathyFJ]. Technol Health Care,2013,21(6) :557-569.
  • 6Oh E, Yoo TK,Park EC. Diabetic retinopathy risk predic- tion for fundus examination using sparse learning:a cross- sectional study[J]. BMC Med Inform Decis Mak, 2013,13 (1) :106-110.
  • 7Noonan JE, Jenkins AJ, Ma JX, et aI. An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes[J]. Diabetes, 2013,62 ( 12 ) : 3968- 3975.
  • 8Mishra A, Newman EA. Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinop- athy[J]. Front Neuroenergetics,2012,10(3) : 10-15.
  • 9Shazly AH, Mahmoud AM,Darwish NS. Potential proph- ylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals [J]. Acta Pharm, 2009,59(1) :67-73.
  • 10Lopez-Costa J J, Goldstein J, Saavedra JP. Neuronal and maerophagic nitric oxide synthase isoforms distribution in normal rat retina[J]. Neurosci Lett, 1997,232 (3) : 155- 158.

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部